Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (Q3842893): Difference between revisions
From MaRDI portal
Latest revision as of 14:53, 28 May 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials |
scientific article |
Statements
Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials (English)
0 references
30 June 1999
0 references
conditional independence
0 references
exponential components
0 references
colorectal adjuvant clinical trials
0 references
